CTP to predict Response to recanalization in Ischemic Stroke Project (CRISP)
CTP 预测缺血性中风再通反应项目 (CRISP)
基本信息
- 批准号:8431810
- 负责人:
- 金额:$ 56.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-01 至 2016-02-29
- 项目状态:已结题
- 来源:
- 关键词:Accident and Emergency departmentAlgorithmsBenefits and RisksBlood flowBrainBrain MappingCerebral hemisphere hemorrhageCessation of lifeClinicalClinical DataClinical TrialsCohort StudiesComputer Retrieval of Information on Scientific Projects DatabaseComputer softwareDataDependenceEmergency SituationGoalsHeadHospitalsHourHousingImageInfarctionInjuryInterventionIschemic StrokeLeadMRI ScansMagnetic Resonance ImagingMalignant - descriptorMapsMethodsOdds RatioOutcomePatient SchedulesPatient SelectionPatientsPerfusionPhysiciansPopulationProceduresProcessRandomized Controlled TrialsRecruitment ActivityReperfusion TherapyResearchScanningSiteSolutionsStrokeSystemTechnologyTestingTissuesUnited StatesUniversitiesX-Ray Computed Tomographyacute strokebaseclinical practicecohortdesigndisabilitydisability burdeneffective therapyexperiencefollow-upinclusion criteriaprogramsprospectiverandomized placebo controlled trialrandomized trialresponserestorationstandard of caretool
项目摘要
Project Summary
Stroke is the number one cause of disability in the United States. In order to reduce the burden of disability
caused by stroke there is a need for better stroke treatments that are available to more stroke victims.
Endovascular therapies are increasingly being used and may fill this need as they have high rates of
recanalization. It is, however, not known which patients benefit clinically.
Previous studies suggest that stroke patients with a small volume of irreversible ischemic injury (infarct
core) and a large volume of reversible ischemic injury (penumbra) are most likely to benefit from restoration of
blood flow. MRI shows promise for identification of the ischemic core and penumbra but it has very limited
availability in US emergency rooms. Computed Tomography Perfusion (CTP) imaging is a potential solution as
it is widely available and can easily be added to a non-contrast head CT, already routinely obtained to evaluate
stroke patients in the emergency room. However, methods for processing of CTP images and criteria for
interpretation of the images are still immature. Therefore, patient selection based on CTP images is not ready
for implementation in clinical trials or clinical practice.
The overall goal of the CTP to predict Response to recanalization in Ischemic Stroke Project (CRISP) is to
develop a practical tool to identify acute stroke patients who are likely to benefit from endovascular therapy.
The project has two main parts. During the first part (year 1), we propose to develop a fully automated
system (RAPID) for processing of CT Perfusion (CTP) images that will generate brain maps of the ischemic
core and penumbra. We will also define criteria, based on these CTP maps, which predict if a patient is likely
to benefit from restoration of blood flow. These criteria will be based on data from a retrospective cohort of 95
patients treated at St Luke's hospital.
During the second part (years 2-5), we aim to demonstrate that physicians in the emergency setting, with
the aid of a fully automated CTP analysis program (RAPID), can accurately predict response to recanalization
in stroke patients undergoing revascularization. To achieve this aim we will conduct a prospective cohort study
of 100 consecutive stroke patients who will undergo a CTP scan prior to endovascular therapy. The study will
be conducted at two sites (Stanford University and St Luke's Hospital). Patients will have an early follow-up
scan within 6 hours to assess reperfusion and a late follow-up scan at day 5 to determine the final infarct.
The successful execution of this research will provide physicians with an easy, automated method to select
patients who are likely to benefit from restoration of blood flow. Such a method, thanks to easy accessibility to
CT technology, would be of great value for patient selection in multi-center clinical acute stroke trials and,
eventually, in routine clinical practice.
项目概要
中风是美国第一大致残原因。为了减轻残疾负担
中风引起的中风需要更好的中风治疗方法,以供更多的中风患者使用。
血管内治疗的使用越来越多,并且可能满足这一需求,因为它们的发生率很高。
再通。然而,尚不清楚哪些患者在临床上受益。
既往研究表明,中风患者存在小体积不可逆的缺血性损伤(梗死)
核心)和大量可逆性缺血性损伤(半影)最有可能受益于恢复
血流(量。 MRI 显示了识别缺血核心和半暗带的希望,但其局限性非常有限
美国急诊室的可用性。计算机断层扫描灌注 (CTP) 成像是一种潜在的解决方案
它应用广泛,可以轻松添加到非对比头部 CT 中,已常规获取用于评估
急诊室里的中风患者。然而,CTP图像的处理方法和标准
对图像的解释仍然不成熟。因此,基于CTP图像的患者选择还没有准备好
用于临床试验或临床实践中的实施。
CTP 预测缺血性中风项目 (CRISP) 中再通反应的总体目标是
开发一种实用工具来识别可能受益于血管内治疗的急性中风患者。
该项目有两个主要部分。在第一部分(第一年),我们建议开发一个完全自动化的
系统 (RAPID),用于处理 CT 灌注 (CTP) 图像,生成缺血性脑图
核心和半影。我们还将根据这些 CTP 图定义标准,预测患者是否可能
受益于血流的恢复。这些标准将基于 95 名患者的回顾性队列数据
在圣卢克医院接受治疗的病人。
在第二部分(2-5 年),我们的目标是证明医生在紧急情况下,
借助全自动 CTP 分析程序 (RAPID),可以准确预测再通反应
接受血运重建的中风患者。为了实现这一目标,我们将进行一项前瞻性队列研究
100 名连续中风患者在血管内治疗前接受 CTP 扫描。该研究将
在两个地点(斯坦福大学和圣卢克医院)进行。患者将得到早期随访
6 小时内扫描以评估再灌注,并在第 5 天进行后期随访扫描以确定最终梗塞情况。
这项研究的成功执行将为医生提供一种简单、自动化的方法来选择
可能受益于血流恢复的患者。这种方法,由于易于访问
CT技术对于多中心临床急性卒中试验的患者选择具有重要价值,
最终,在常规临床实践中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MAARTEN G LANSBERG其他文献
MAARTEN G LANSBERG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MAARTEN G LANSBERG', 18)}}的其他基金
ARCADIA CSI (Cognition and Silent Infarcts)
ARCADIA CSI(认知和无症状梗塞)
- 批准号:
10207805 - 财政年份:2019
- 资助金额:
$ 56.13万 - 项目类别:
ARCADIA CSI (Cognition and Silent Infarcts)
ARCADIA CSI(认知和无症状梗塞)
- 批准号:
10450768 - 财政年份:2019
- 资助金额:
$ 56.13万 - 项目类别:
CT Perfusion to Predict Response to Recanalization in Ischemic Stroke Project 2 (CRISP 2)
CT 灌注预测缺血性中风再通反应项目 2 (CRISP 2)
- 批准号:
9923737 - 财政年份:2011
- 资助金额:
$ 56.13万 - 项目类别:
CTP to predict Response to recanalization in Ischemic Stroke Project (CRISP)
CTP 预测缺血性中风再通反应项目 (CRISP)
- 批准号:
8623151 - 财政年份:2011
- 资助金额:
$ 56.13万 - 项目类别:
CTP to predict Response to recanalization in Ischemic Stroke Project (CRISP)
CTP 预测缺血性中风再通反应项目 (CRISP)
- 批准号:
8246275 - 财政年份:2011
- 资助金额:
$ 56.13万 - 项目类别:
CT Perfusion to Predict Response to Recanalization in Ischemic Stroke Project 2 (CRISP 2)
CT 灌注预测缺血性中风再通反应项目 2 (CRISP 2)
- 批准号:
10397021 - 财政年份:2011
- 资助金额:
$ 56.13万 - 项目类别:
CTP to predict Response to recanalization in Ischemic Stroke Project (CRISP)
CTP 预测缺血性中风再通反应项目 (CRISP)
- 批准号:
8327166 - 财政年份:2011
- 资助金额:
$ 56.13万 - 项目类别:
CT Perfusion to Predict Response to Recanalization in Ischemic Stroke Project 2 (CRISP 2)
CT 灌注预测缺血性中风再通反应项目 2 (CRISP 2)
- 批准号:
10611971 - 财政年份:2011
- 资助金额:
$ 56.13万 - 项目类别:
Who Benefits from tPA 3-6 hours after Stroke
中风后 3-6 小时谁可以从 tPA 中受益
- 批准号:
7034723 - 财政年份:2006
- 资助金额:
$ 56.13万 - 项目类别:
Who Benefits from tPA 3-6 hours after Stroke
中风后 3-6 小时谁可以从 tPA 中受益
- 批准号:
7615482 - 财政年份:2006
- 资助金额:
$ 56.13万 - 项目类别:
相似国自然基金
基于肿瘤病理图片的靶向药物敏感生物标志物识别及统计算法的研究
- 批准号:82304250
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多模态高层语义驱动的深度伪造检测算法研究
- 批准号:62306090
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
高精度海表反照率遥感算法研究
- 批准号:42376173
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
基于新型深度学习算法和多组学研究策略鉴定非编码区剪接突变在肌萎缩侧索硬化症中的分子机制
- 批准号:82371878
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于深度学习与水平集方法的心脏MR图像精准分割算法研究
- 批准号:62371156
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Use Bayesian methods to facilitate the data integration for complex clinical trials
使用贝叶斯方法促进复杂临床试验的数据集成
- 批准号:
10714225 - 财政年份:2023
- 资助金额:
$ 56.13万 - 项目类别:
The Comparative Effectiveness and Safety of Oral Anticoagulants in Patients with Cirrhosis and Atrial Fibrillation
口服抗凝药对肝硬化合并心房颤动患者的有效性和安全性比较
- 批准号:
10559071 - 财政年份:2023
- 资助金额:
$ 56.13万 - 项目类别:
Small molecules combination therapy using polypharmacology approach as a novel treatment paradigm for rare bone disease
使用多药理学方法的小分子联合疗法作为罕见骨病的新型治疗范例
- 批准号:
10759694 - 财政年份:2023
- 资助金额:
$ 56.13万 - 项目类别:
Ex Vivo Imaging of the Aging Brain to Discover Morphology/Pathology Associations
衰老大脑的离体成像以发现形态学/病理学关联
- 批准号:
10608603 - 财政年份:2023
- 资助金额:
$ 56.13万 - 项目类别: